SECURITIES AND EXCHANGE COMMISSION
                                WASHINGTON, D.C. 20549

                                    ______________


                                       FORM 8-K


                                    CURRENT REPORT


                        PURSUANT TO SECTION 13 OR 15(d) of the
                           SECURITIES EXCHANGE ACT OF 1934




          Date of Report (Date of earliest event reported): June 30, 1995



                             DENTSPLY International Inc.
                (Exact name of registrant as specified in its charter)



                     Delaware             0-16211           39-1434669
          (State or other jurisdiction  (Commission        (IRS Employer
                of incorporation)       File Number)    Identification No.)



                  570 West College Avenue, York, PA         17405-0872
               (Address of principal executive offices)     (Zip code)



          Registrant's telephone number, including area code: 717-845-7511








                                 Page 1 of 26 pages.
                               Exhibit Index on page 5.


          Item 2.   Acquisition or Disposition of Assets.

                    On June 30, 1995, DENTSPLY International Inc., a
          Delaware corporation (the "Company"), through Dentsply Ltd., a
          corporation registered in the British Cayman Islands and a wholly
          owned subsidiary of the Company ("Purchaser"), consummated the
          acquisition (the "Purchase") of approximately 96% of the
          outstanding shares of capital stock (the "Shares") of Maillefer
          Instruments S.A., a corporation organized under the laws of
          Switzerland ("Maillefer"), pursuant to a Sales-Purchase Agreement
          dated May 30, 1995 (the "Agreement") between certain stockholders
          of Maillefer (the "Sellers"), Purchaser, and the Company as
          guarantor.  The purchase price was SFr. 11,000 cash per Share
          (the "Purchase Price"), with the aggregate Purchase Price for all
          Shares acquired in the Purchase being approximately $66,000,000,
          subject to adjustment as described below.

                    Pursuant to the Agreement, 7.5% of the aggregate
          Purchase Price (approximately $4,950,000) has been placed in
          escrow (the "Escrow Fund") to be subject to claims by Purchaser
          for a reduction of the aggregate Purchase Price based upon
          breaches of the representations and warranties of the Sellers
          under the Agreement, including a representation as to the total
          adjusted stockholders' equity of the Company at December 31,
          1994.  Any claim for a reduction of the aggregate Purchase Price
          must be in an amount in excess of SFr. 200,000.  If no claim is
          asserted prior to the 90th day after the first anniversary of the
          Purchase, all but SFr. 2,000,000 of the Escrow Fund will be
          released to the Sellers; the remainder of the Escrow Fund (if
          any) will be released to the Sellers 90 days after the fifth
          anniversary of the Purchase.  The balance remaining at any time
          in the Escrow Fund will be Purchaser's sole recourse for claims
          made under the Agreement.

                    The funds used by Purchaser to pay the aggregate
          Purchase Price were obtained from (i) a new $60.0 million term
          loan which has the same maturity date, interest rate structure
          and covenants as the Company's existing $175.0 million Bank
          Revolving Loan Facility, (ii) short-term bank borrowings made by
          a bank in the ordinary course of business and (iii) cash on hand. 
          The identities of the banks from which the borrowings referred to
          in clauses (i) and (ii) of the preceding sentence were made have
          been omitted in accordance with Section 13(d)(1)(B) of the
          Securities Exchange Act of 1934, as amended, and Item 2(a) of
          Form 8-K, and have been filed separately with the Securities and
          Exchange Commission.







                                          2



          Item 7.   Financial Statements, Pro Forma Financial Information
                    and Exhibits.

                    (a)  Financial Statements of Businesses Acquired.  It
          is impracticable for the Company to provide the financial
          statements of Maillefer required by this Item 7(a) at the time of
          filing of this report on Form 8-K, and none of such financial
          statements are available at such time.  Accordingly, in
          accordance with Item 7(a)(4) of Form 8-K, the Company will file
          the required financial statements of Maillefer in an amendment to
          this report on Form 8-K as soon as is practicable, but not later
          than 60 days after July 17, 1995.

                    (b)  Pro Forma Financial Information.  It is
          impracticable for the Company to provide the pro forma financial
          information relative to Maillefer required by this Item 7(b) at
          the time of filing of this report on Form 8-K, and none of such
          pro forma financial information is available at such time. 
          Accordingly, in accordance with Item 7(b)(2) of Form 8-K, the
          Company will file the required pro forma financial information
          relative to Maillefer in an amendment to this report on Form 8-K
          as soon as is practicable, but not later than 60 days after
          July 17, 1995.

                    (c)  Exhibits.

                    Exhibit No.              Description
                    -----------              -----------

                        2.1        Sales-Purchase Agreement, dated May 30,
                                   1995, between certain stockholders of
                                   Maillefer Instruments S.A., Dentsply
                                   Ltd., and DENTSPLY International Inc. as
                                   guarantor.



















                                          3



                                      SIGNATURE

                    Pursuant to the requirements of the Securities Exchange
          Act of 1934, the registrant has duly caused this report to be
          signed on its behalf by the undersigned hereunto duly authorized.


                                        DENTSPLY International Inc.


          Date:  July 17, 1995          By:  /s/ J. Patrick Clark
                                             -----------------------------
                                             J. Patrick Clark
                                             Vice President, Secretary and
                                             General Counsel






































                                          4


                                    EXHIBIT INDEX

                                                                 Sequential
          Exhibit No.              Description                    Page No.
          -----------              -----------                   ----------

              2.1        Sales-Purchase Agreement, dated              6
                         May 30, 1995, between certain
                         stockholders of Maillefer
                         Instruments S.A., Dentsply Ltd.,
                         and DENTSPLY International Inc. as
                         guarantor.









































                                          5